Surface plasmon resonance for the analysis of β-amyloid interactions and fibril formation in alzheimer's disease research

Neurotoxicity Research

Volumn 7, Issue 1-2, 2005, Pages 17-27

  Aguilar, Marie Isabel ^a   Small, David H ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Amyloid; Fibril formation; Membrane interactions; Surface plasmon resonance

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL; HUMAN; METABOLISM; METHODOLOGY; REVIEW; SURFACE PLASMON RESONANCE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; PEPTIDE FRAGMENTS; SURFACE PLASMON RESONANCE;

EID: 15844369794     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033773     Document Type: Review

References (51)

1. Ariga T and RK Yu (1999) GM1 inhibits amyloid beta-proteininduced cytokine release. Neurochem. Res. 24, 219-226.
2. Ariga T, K Kobayashi, A Hasegawa, M Kiso, H Ishida and T Miyatake (2001) Characterization of high-affinity binding between gangliosides and amyloid beta-protein. Arch. Biochem. Biophys. 388, 225-230.
3. Barbier A, A Visvikis, F Mathieu, L Diez, LM Havekes and G Siest (1997) Characterization of three human apolipoprotein E iso-forms (E2, E3 and E4) expressed in Escherichia coli. Eur. J. Clin. Chem. Clin. Biochem. 35, 581-589.
4. Baumann MH, J Kallijarvi, H Lankinen, C Soto and M Haltia (2000) Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides. Biochem. J. 349, 77-84.
5. Bohrmann B, L Tjernberg, P Kuner, S Poli, B Levet-Trafit, J Naslund, G Richards, W Huber, H Dobeli and C Nordstedt (1999) Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues. J. Biol. Chem. 274, 15990-15995.
6. Bohrmann B, M Adrian, J Dubochet, P Kuner, F Muller, W Huber, C Nordstedt and H Dobeli (2000) Self-assembly of beta-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates. J. Struct. Biol. 130, 232-246.
7. Cairo CW, A Strzelec, RM Murphy and LL Kiessling (2002) Affinity-based inhibition of beta-amyloid toxicity. Biochemistry 41, 8620-8629.
8. Cannon MJ, AD Williams, R Wetzel and DG Myszka (2004) Kinetic analysis of beta-amyloid fibril elongation. Anal. Biochem. 328, 67-75.
9. Cooper MA (2002) Optical biosensors in drug discovery. Nat. Rev. DrugDiscov. 1, 515-528.
10. Cooper MA, A Hansson, S Lofas and DH Williams (2000) A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors. Anal. Biochem. 277, 196-205.
11. Corder EH, AM Saunders, WJ Strittmatter, DE Schmechel, PC Gaskell, GW Small, AD Roses, JL Haines and MA Pericak-Vance (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
12. Dong J, CA Peters-Libeu, KH Weisgraber, BW Segelke, B Rupp, I Capila, MJ Hernaiz, LA LeBrun and RJ Linhardt (2001) Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Biochemistry 40, 2826-2834.
13. Esler WP, ER Stimson, JM Jennings, HV Vinters, JR Ghilardi, JP Lee, PW Mantyh and JE Maggio (2000) Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39, 6288-6295.
14. Hasegawa K, K Ono, M Yamada and H Naiki (2002) Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance. Biochemistry 41, 13489-13498.
15. Hernaiz MJ, LA LeBrun, Y Wu, JW Sen, RJ Linhardt and NY Heegaard (2002) Characterization of heparin binding by a peptide from amyloid P component using capillary electrophoresis, surface plasmon resonance and isothermal titration calorimetry. Eur. J. Biochem. 269, 2860-2867.
16. Hertel C, E Terzi, N Hauser, R Jakob-Rotne, J Seelig and JA Kemp (1997) Inhibition of the electrostatic interaction between betaamyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc. Natl. Acad. Sci. USA 94, 9412-9416.
17. Hoffmann J, CU Pietrzik, MP Kummer, C Twiesselmann, C Bauer and V Herzog (1999) Binding and selective detection of the secretory N-terminal domain of the alzheimer amyloid precursor protein on cell surfaces. J. Histochem. Cytochem. 47, 373-3820.
18. Jarrett JT and PT Lansbury Jr (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
19. Jarvik GP, EM Wijsman, WA Kukull, GD Schellenberg, C Yu and EB Larson (1995) Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study. Neurology 45, 1092-1096.
20. Kremer JJ and RM Murphy (2003) Kinetics of adsorption of betaamyloid peptide Aβ(1-40) to lipid bilayers. J. Biochem. Biophys. Methods 57, 159-169.
21. Lashuel HA, D Hartley, BM Petre, T Walz and PT Lansbury Jr (2002) Neurodegenerative disease: Amyloid pores from pathogenic mutations. Nature 418, 291.
22. Maggio JE, ER Stimson, JR Ghilardi, CJ Allen, CE Dahl, DC Whitcomb, SR Vigna, HV Vinters, ME Labenski and PW Mantyh (1992) Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc. Natl. Acad. Sci. USA 89, 5462-5466.
23. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
24. Mattson MP and SL Chan (2003) Good and bad amyloid antibodies. Science 301, 1847-1849.
25. Monsonego A and HL Weiner (2003) Immunotherapeutic approaches to Alzheimer's disease. Science 302, 834-838.
26. Mozsolits H and MI Aguilar (2002) Surface plasmon resonance spectroscopy: An emerging tool for the study of peptide-membrane interactions. Biopolymers 66, 3-18.
27. Mozsolits H, WG Thomas and ML Aguilar (2003) Surface plasmon resonance spectroscopy in the study of membrane-mediated cell signalling. J. Pept. Sci. 9, 77-89.
28. Multhaup G, AI Bush, P Pollwein and CL Masters (1994) Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP). FEBS Lett. 355, 151-154.
29. Multhaup G, H Mechler and CL Masters (1995) Characterization of the high affinity heparin binding site of the Alzheimer's diseaseβA4 amyloid precursor protein (APP) and its enhancement by zinc(II) Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP). J. Mol. Recognit. 8, 247-257.
30. Myszka DG, SJ Wood and AL Biere (1999) Analysis of fibril elongation using surface plasmon resonance biosensors. Methods Enzymol. 309, 386-402.
31. Notkola IL, R Sulkava, J Pekkanen, T Erkinjuntti, C Ehnholm, P Kivinen, J Tuomilehto and A Nissinen (1998) Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17, 14-20.
32. Nunan J and DH Small (2002) Proteolytic processing of the amyloid-beta protein precursor of Alzheimer's disease. Essays Biochem. 38, 37-49.
33. Plant AL, M Brigham-Burke, EC Petrella and DJ O'Shannessy (1995) Phospholipid/alkanethiol bilayers for cell-surface receptor studies by surface plasmon resonance. Anal. Biochem. 226, 342-348.
34. Redondo C, AM Damas, A Olofsson, E Lundgren and MJ Saraiva (2000) Search for intermediate structures in transthyretin fibrillogenesis: Soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils. J. Mol. Biol. 304, 461-470.
35. Rich RL and DG Myszka (2000) Advances in surface plasmon resonance biosensor analysis. Curr. Opin. Biotechnol. 11, 54-61.
36. Scheuner D, C Eckman, M Jensen, X Song, M Citron, N Suzuki, TD Bird, J Hardy, M Hutton, W Kukull, E Larson, E Levy-Lahad, M Viitanen, E Peskind, P Poorkaj, G Schellenberg, R Tanzi, W Wasco, L Lannfelt, D Selkoe and S Younkin (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864-870.
37. Shuvaev W and G Siest (1996) Interaction between human amphipathic apolipoproteins and amyloid beta-peptide: Surface plasmon resonance studies. FEBS Lett. 383, 9-12.
38. Shuvaev W and G Siest (2000) Heparin specifically inhibits binding of apolipoprotein E to amyloid beta-peptide. Neurosci. Lett. 280, 131-134.
39. Small DH and CA McLean (1999) Alzheimer's disease and the amyloid β protein: What is the role of amyloid? J. Neurochem. 73, 443-449.
40. Small DH, SS Mok and JC Bornstein (2001) Alzheimer's disease and Aβ toxicity: From top to bottom. Nat. Rev. Neurosci. 2, 595-598.
41. Subasinghe S, S Unabia, CJ Barrow, SS Mok, MI Aguilar and DH Small (2003) Cholesterol is necessary both for the toxic effect of Aβ peptides on vascular smooth muscle cells and for Aβ binding to vascular smooth muscle cell membranes. J. Neurochem. 84, 471-479.
42. Tanzi RE and L Bertram(2001) New frontiers in Alzheimer's disease genetics. Neuron 32, 181-184.
43. Terrettaz S, T Stora et al. (1993) Protein binding to supported lipid membranes: Investigation of the cholera toxin-ganglioside interaction by simultaneous impedance spectrosopy and surface plasmon spectroscopy. Langmuir 9, 1361-1369.
44. Tjernberg LO, J Naslund, F Lindqvist, J Johansson, AR Karlstrom, J Thyberg, L Terenius and C Nordstedt (1996) Arrest of β-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271, 8545-8548.
45. Valdes-Gonzalez T, J Inagawa and T Ido (2001) Neuropeptides interact with glycolipid receptors: A surface plasmon resonance study. Peptides 22, 1099-1106.
46. Vorum H, C Jacobsen and B Honore (2000) Calumenin interacts with serum amyloid P component. FEBS Lett. 465, 129-134.
47. Wirths O, G Multhaup, C Czech, N Feldmann, V Blanchard, G Tremp, K Beyreuther, L Pradier and TA Bayer (2002) Intraneuronal APP/Aβ trafficking and plaque formation in betaamyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol. 12, 275-286.
48. Wood SJ, W Chan et al. (1996) An ApoE-Aβ inhibition complex in Aβ fibril extension. Chem. Biol. 3, 949-956.
49. Yankner BA, LR Dawes, S Fisher, L Villa-Komaroff, ML Oster-Granite and RL Neve (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420.
50. Zambrano N,JD Buxbaum, G Minopoli, F Fiore, P De Candia, S De Renzis, R Faraonio, S Sabo, J Cheetham, M Sudol and T Russo (1997) Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's β-amyloid precursor proteins. J. Biol. Chem. 272, 6399-6405.
51. Zhang L,CA Booth and P Stroeve (2000) Phosphatidylserine/cholesterol bilayers supported on a polycation/alkylthiol layer pair. J. Colloid Interface Sci. 228, 82-89.